The week in health tech, explained in plain English.Get the free newsletter →
October 26, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Government

Medicare Rule Could Cut Remote Patient Monitoring Access

A proposed federal rule from the Centers for Medicare & Medicaid Services could dramatically reduce access to remote patient monitoring for people on Medicare, according to KFF Health News. The services send patients home with connected devices that track blood pressure, glucose, weight, and other vitals, with the goal of catching problems early and keeping people out of the hospital.

Current rules generally require 16 days of readings in a 30-day period before providers can bill. The proposal would allow payment based on fewer days of data, a shift supporters frame as more flexible but that critics warn would cut reimbursement and push some programs to shut down. The tension reflects a broader problem: remote monitoring billing has surged in recent years even as evidence on whether it improves outcomes remains thin, and oversight is limited.

The stakes are highest for rural and chronically ill patients who rely on at-home monitoring to avoid long trips to clinics. CMS must now weigh cost control and fraud concerns against the risk of stranding vulnerable patients.

More in Government

Government

HHS Launches National Plan to Overhaul US Kidney Care

HHS launched a national kidney care plan centered on prevention, dialysis reform with more patient choice, and overhauling the transplant system.

Why it matters: Kidney disease affects 1 in 7 US adults and drives major Medicare spending, so federal direction here reshapes care models and markets.

Government

FDA Approves First Once-Weekly Insulin for Children

The FDA approved Novo Nordisk's Awiqli, the first once-weekly basal insulin for children 10 and older with Type 2 diabetes.

Why it matters: Weekly rather than daily insulin could improve adherence for a growing number of children with Type 2 diabetes.

Government

Feds Launch False Claims Act Self-Disclosure Pilot

HHS and the DOJ Civil Division have launched a six-month pilot letting healthcare companies self-report potential civil False Claims Act violations and settle through a coordinated civil release.

Why it matters: The pilot reshapes how hospitals and healthcare firms weigh self-reporting against federal fraud enforcement, with real consequences for compliance strategy.